Skip to main content

Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today.

Publication ,  Journal Article
Jafar, TH
Published in: European review for medical and pharmacological sciences
January 2005

Despite the high prevalence and significant morbidity and mortality associated with high chronic kidney disease (CKD) in patients with hypertension, it remains vastly under-diagnosed and under-treated. Consequently, many patients develop kidney failure requiring dialysis or kidney transplant. Moreover, patients with CKD represent the group at highest risk from cardiovascular complications, even greater than patients with diabetes mellitus. Therefore, management of hypertension in such patients needs to be more aggressive compared to those with normal kidney function. This review provides guidelines for treatment of hypertension in patients with non-diabetic CKD based on updated evidence from clinical trials data. Following these recommendations is likely to minimize the risk of development of kidney failure and cardiovascular disease.

Duke Scholars

Published In

European review for medical and pharmacological sciences

EISSN

2284-0729

ISSN

1128-3602

Publication Date

January 2005

Volume

9

Issue

1

Start / End Page

1 / 12

Related Subject Headings

  • Kidney Failure, Chronic
  • Kidney Diseases
  • Hypertension, Renal
  • Humans
  • Gastroenterology & Hepatology
  • Chronic Disease
  • Antihypertensive Agents
  • Albuminuria
  • 3404 Medicinal and biomolecular chemistry
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jafar, T. H. (2005). Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today. European Review for Medical and Pharmacological Sciences, 9(1), 1–12.
Jafar, T. H. “Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today.European Review for Medical and Pharmacological Sciences 9, no. 1 (January 2005): 1–12.
Jafar TH. Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today. European review for medical and pharmacological sciences. 2005 Jan;9(1):1–12.
Jafar, T. H. “Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today.European Review for Medical and Pharmacological Sciences, vol. 9, no. 1, Jan. 2005, pp. 1–12.
Jafar TH. Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today. European review for medical and pharmacological sciences. 2005 Jan;9(1):1–12.

Published In

European review for medical and pharmacological sciences

EISSN

2284-0729

ISSN

1128-3602

Publication Date

January 2005

Volume

9

Issue

1

Start / End Page

1 / 12

Related Subject Headings

  • Kidney Failure, Chronic
  • Kidney Diseases
  • Hypertension, Renal
  • Humans
  • Gastroenterology & Hepatology
  • Chronic Disease
  • Antihypertensive Agents
  • Albuminuria
  • 3404 Medicinal and biomolecular chemistry
  • 3214 Pharmacology and pharmaceutical sciences